Primary antibody deficiencies (PADs) are a heterogeneous group of disorders, characterized by hypogammaglobulinemia and increased susceptibility to bacterial infections, leading to hospitalizations. This study was performed to determine the main infectious causes of hospital admissions in selective Iranian patients with PADs. Forty patients with PADs, who were admitted to the Infectious Ward of Children's Medical Center Hospital during a 14-year period, were reviewed in this study. There were 115 documented episodes of hospital admission during a 14-year period. The average length of hospital stay was 33.30 ± 25.72 days. Pneumonia was the most prominent infection leading to hospitalization among these patients (n = 48), followed by gastroenteritis (n = 23). Other less frequent causes of hospitalization were fever and neutropenia, septic arthritis, encephalitis, orbital cellulitis, sepsis, urinary tract infection, meningitis, oral ulcer, and lung abscess. The most common causative organisms of diarrhea were: Giardia lamblia, followed by Candida albicans, and Salmonella sp. Many patients with PADs suffer from repeated infections leading to hospitalization, in spite of immunoglobulin replacement therapy. Respiratory tract infections were the prominent cause of hospitalization among studied patients, followed by gastrointestinal infections.
Journal Information
Vol. 14. Issue 4.
Pages 351-355 (July - August 2010)
Vol. 14. Issue 4.
Pages 351-355 (July - August 2010)
Original article
Open Access
A single center 14 years study of infectious complications leading to hospitalization of patients with primary antibody deficiencies
Visits
2656
Setareh Mamishi1,2, Aiden Nasiri Eghbali2, Nima Rezaei1,3,4, Hassan Abolhassani3, Nima Parvaneh1,2, Asghar Aghamohammadi1,3,
Corresponding author
aghamohammadi@sina.tums.ac.ir
Correspondence to: Children's Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran. Tel.(fax:): +98-21-66949662.
Correspondence to: Children's Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran. Tel.(fax:): +98-21-66949662.
1 Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2 Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
3 Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
4 Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
This item has received
Article information
Abstract
Keywords:
infection
hospitalization
primary antibody deficiencies
Full text is only aviable in PDF
References
[1.]
R.S. Geha, L. Notarangelo, J.L. Casanova, et al.
Primary immunodeficiency diseases: an update the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.
J Allergy Clin Immunol, 120 (2007), pp. 776-794
[2.]
A. Aghamohammadi, M. Moein, A. Farhoudi, et al.
Primary immunodeficiency in Iran: First report of the national registry of PID in children and adults.
J Clin Immunol, 22 (2002), pp. 375-380
[3.]
N. Rezaei, A. Aghamohammadi, M. Moin, et al.
Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry.
J Clin Immunol, 26 (2006), pp. 519-532
[4.]
V. Knerr, B. Grimbacher.
Primary immunodeficiency registries.
Curr Opin Allergy Clin Immunol, 7 (2007), pp. 475-480
[5.]
A. Aghamohammadi, A. Farhoudi, M. Moin, et al.
Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency.
Clin Diagn Lab Immunol, 12 (2005), pp. 825-832
[6.]
C. Cunningham-Rundles, C. Bodian.
Common variable immunodeficiency: clinical and immunological features of 248 patients.
Clin Immunol, 92 (1999), pp. 34-48
[7.]
J.A. Winkelstein, M.C. Marino, H.M. Lederman, et al.
X-linked agammaglobulinemia: report on a United States registry of 201 patients.
Medicine (Baltimore), 85 (2006), pp. 193-202
[8.]
A. Aghamohammadi, M. Fiorini, M. Moin, et al.
Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia.
Int Arch Allergy Immunol, 141 (2006), pp. 408-414
[9.]
A. Khodadad, A. Aghamohammadi, N. Parvaneh, et al.
Gastrointestinal manifestations in patients with common variable immunodeficiency.
Dig Dis Sci, 52 (2007), pp. 2977-2983
[10.]
P.J. Busse, S. Razvi, C. Cunningham-Rundles.
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency.
J Allergy Clin Immunol, 109 (2002), pp. 1001-1004
[11.]
A. Aghamohammadi, M. Moin, A. Farhoudi, et al.
Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.
FEMS Immunol Med Microbiol, 40 (2004), pp. 113-118
[12.]
Z. Pourpak, A. Aghamohammadi, L. Sedighipour, et al.
Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.
J Microbiol Immunol Infect, 39 (2006), pp. 114-120
[13.]
P. Quartier, M. Debre, J. De Blic, et al.
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
J Pediatr, 134 (1999), pp. 589-596
[14.]
L. Atarod, A. Aghamohammadi1, M. Moin, et al.
Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
Iran J Allergy Asthma Immunol, 6 (2007), pp. 37-40
[15.]
M.E. Conley, L.D. Notarangelo, A. Etzioni.
Diagnostic criteria for primary immunodeficiencies.
Clin Immunol, 93 (1999), pp. 190-197
[16.]
U. Korthauer, D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, et al.
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Nature, 361 (1993), pp. 539-541
[17.]
P. Revy, T. Muto, Y. Levy, et al.
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
Cell, 102 (2000), pp. 565-575
[18.]
F.S. Rosen, M.D. Cooper, R.J. Wedgwood.
The primary immunodeficiences.
N Eng J Med, 17 (1995), pp. 431-440
[19.]
J.A. Winkelstein, M.C. Marino, H. Ochs, et al.
The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
Medicine (Baltimore), 82 (2003), pp. 373-384
[20.]
L. Kainulainen, J. Nikoskelainen, O. Ruuskanen.
Diagnostic findings in 95 Finnish patients with common variable immunodeficiency.
J Clin Immunol, 21 (2001), pp. 145-149
[21.]
N. Matamoros, J. Flori Mila Llambi, T. Espanol Boren, S. Raga Borja, G. Fontan Casariego.
Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults.
J Clin Immunol, 17 (1997), pp. 333-339
[22.]
R.A. Hermazewski, A.D. Webster.
Primary hypogammaglobulinemia: a survey of clinical manifestations and complications.
Q J Med, 86 (1993), pp. 31-42
[23.]
P.E. Hermans, J.A. Diaz-Buxo, J.D. Stobo.
Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients.
Am J Med, 61 (1976), pp. 221-237
[24.]
C. Hausser, J.L. Virelizier, D. Buriot, C. Griscelli.
Common variable hypogammaglobulinemia in children. Clinical and immunologic observation in 30 patients.
Am J Dis Child, 137 (1983), pp. 833-837
[25.]
C.M. Kokron, P.R. Errante, M.T. Barros, et al.
Clinical and laboratory aspects of common variable immunodeficiency.
An Acad Bras Cienc, 76 (2004), pp. 707-726
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved